Mml Investors Services, LLC Macrogenics Inc Transaction History

Mml Investors Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $221,087 - $321,440	-11,200 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$20.49 - $35.63 $229,487 - $399,056	11,200 New	11,200 $301,000
Q1 2021 May 14, 2021	SELL	$18.99 - $33.2 $594,387 - $1.04 Million	-31,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$19.41 - $26.0 $607,533 - $813,800	31,300 New	31,300 $716,000
Q4 2019 Feb 11, 2020	SELL	$7.95 - $12.27 $109,710 - $169,326	-13,800 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.44 - $17.48 $171,672 - $241,224	13,800 New	13,800 $176,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Mml Investors Services, LLC with notifications on news.